Những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 6/8 đến ngày 13/82021. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.
SCIENCEDIRECT
1. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2
Virology, 9 February 2021, Volume 557 (Cover date: May 2021), Pages 15-22
Teodora Djukic, Maja Mladenovic, Tanja Cirkovic Velickovic
https://www.sciencedirect.com/science/article/pii/S004268222100012X/pdfft?md5=324081ca4494fee185f6bb567d004428&pid=1-s2.0-S004268222100012X-main.pdf
2. Evaluation of the susceptibility and fatality of lung cancer patients towards the COVID-19 infection: A systemic approach through analyzing the ACE2, CXCL10 and their co-expressed genes
Current Research in Microbial Sciences, 9 February 2021, Volume 2 (Cover date: December 2021), Article 100022
Tousif Bin Mahmood, Afrin Sultana Chowdhury, Mohammad Imran Hossan
https://www.sciencedirect.com/science/article/pii/S2666517421000031/pdfft?md5=efd4d1354e5abd7f170d382892e0b66a&pid=1-s2.0-S2666517421000031-main.pdf
3. Assay dependence of long-term kinetics of SARS-CoV-2 antibodies
Diagnostic Microbiology and Infectious Disease, 22 April 2021Volume 100, Issue 4 (Cover date: August 2021), Article 115403
Anneleen Schallier, Sarah De Baets, Pedro Couck
https://www.sciencedirect.com/science/article/pii/S0732889321000961/pdfft?md5=94aa8083bf5e7419e7c5a7276a707659&pid=1-s2.0-S0732889321000961-main.pdf
4. Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
International Immunopharmacology, 22 January 2021, Volume 93 (Cover date: April 2021), Article 107407
Esmaeil Mortaz, Ali Bassir, Ian M. Adcock
https://www.sciencedirect.com/science/article/pii/S1567576921000436/pdfft?md5=61eefb6914f73e6bc202616df2d679e5&pid=1-s2.0-S1567576921000436-main.pdf
5. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients
Microbial Pathogenesis, 4 February 2021, Volume 153 (Cover date: April 2021), Article 104779
Mehdi Shahbazi, Zahra Moulana, Mousa Mohammadnia-Afrouzi
https://www.sciencedirect.com/science/article/pii/S0882401021000516/pdfft?md5=c2c9c2b29922b0a556a3a83e56c737ae&pid=1-s2.0-S0882401021000516-main.pdf
6. Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study
International Journal of Infectious Diseases, 24 May 2021, Volume 108 (Cover date: July 2021), Pages 159-166
Antonia Anna Lukito, Allen Widysanto, Irawan Yusuf
https://www.sciencedirect.com/science/article/pii/S1201971221004203/pdfft?md5=9b391516038fba049162734790a5d04d&pid=1-s2.0-S1201971221004203-main.pdf
7. Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents
Medical Hypotheses, 5 June 2021, Volume 153 (Cover date: August 2021), Article 110622
Paul E. Alexander, Robin Armstrong, Kulvinder K. Gill
https://www.sciencedirect.com/science/article/pii/S0306987721001419/pdfft?md5=fc05ca3a0568f4948ffbf37195da3da8&pid=1-s2.0-S0306987721001419-main.pdf
8. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system
Cell, 2 March 2021, Volume 184, Issue 8 (Cover date: 15 April 2021), Pages 2212-2228.e12
Man Lung Yeung, Jade Lee Lee Teng, Kwok-Yung Yuen
https://www.sciencedirect.com/science/article/pii/S009286742100283X/pdfft?md5=47997610ceaec1876d55387b1986d3d0&pid=1-s2.0-S009286742100283X-main.pdf
9. Epidemiological and clinical presentations of hospitalized COVID-19 patients in Libya: An initial report from Africa
Travel Medicine and Infectious Disease, 18 April 2021, Volume 42 (Cover date: July–August 2021), Article 102064
Muhammed Elhadi, Ahmed Abdulhakim Momen, Hazem Abdelkarem Faraj
https://www.sciencedirect.com/science/article/pii/S1477893921001058/pdfft?md5=13815dfe5ce7c3e48cf6e23507bbeb4f&pid=1-s2.0-S1477893921001058-main.pdf
10. Comparison of four PCR and two point of care assays used in the laboratory detection of SARS-CoV-2
Journal of Virological Methods, 16 April 2021, Volume 293 (Cover date: July 2021), Article 114165
Bence Kenyeres, Noel Ánosi, György Lengyel
https://www.sciencedirect.com/science/article/pii/S016609342100104X/pdfft?md5=6592969edd82cf1fd9297e1559604322&pid=1-s2.0-S016609342100104X-main.pdf
11. SARS-CoV-2 infection in patients with primary mitochondrial diseases: Features and outcomes in Italy
Mitochondrion, 30 March 2021, Volume 58 (Cover date: May 2021), Pages 243-245
Michelangelo Mancuso, Chiara La Morgia, Valerio Carelli
https://www.sciencedirect.com/science/article/pii/S156772492100043X/pdfft?md5=8437a79bf1d116aa0790240cf73f3981&pid=1-s2.0-S156772492100043X-main.pdf
12. Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients
Life Sciences, 27 March 2021, Volume 276 (Cover date: 1 July 2021), Article 119376
Simone R. Potje, Tiago J. Costa, Rita C. Tostes
https://www.sciencedirect.com/science/article/pii/S0024320521003611/pdfft?md5=6f4cb76eeb0d09d40f9ce438c2717300&pid=1-s2.0-S0024320521003611-main.pdf
13. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada
EBioMedicine, 2 April 2021, Volume 66 (Cover date: April 2021), Article 103316
Aidan M. Nikiforuk, Kevin S. Kuchinski, Inna Sekirov
https://www.sciencedirect.com/science/article/pii/S2352396421001092/pdfft?md5=04cdacfd1722edae23829ef313a986b6&pid=1-s2.0-S2352396421001092-main.pdf
14. Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens
Pathology - Research and Practice, 19 April 2021, Volume 221 (Cover date: May 2021), Article 153451
Matteo Fassan, Claudia Mescoli, Angelo Paolo Dei Tos
https://www.sciencedirect.com/science/article/pii/S0344033821001126/pdfft?md5=5d815f24bdd86f2a48f1aaea9bc01f6a&pid=1-s2.0-S0344033821001126-main.pdf
15. Comparative research on nucleocapsid and spike glycoprotein as the rapid immunodetection targets of COVID-19 and establishment of immunoassay strips
Molecular Immunology, 9 January 2021, Volume 131 (Cover date: March 2021), Pages 6-12
Dan Liu, Feng Wu, Lan Ma
https://www.sciencedirect.com/science/article/pii/S0161589021000055/pdfft?md5=0d76ffac90425eac0d76d0186d9469ce&pid=1-s2.0-S0161589021000055-main.pdf
16. A rapid diagnosis of SARS-CoV-2 using DNA hydrogel formation on microfluidic pores
Biosensors and Bioelectronics, 18 January 2021, Volume 177 (Cover date: 1 April 2021), Article 113005
Hwang-soo Kim, Naseem Abbas, Sehyun Shin
https://www.sciencedirect.com/science/article/pii/S0956566321000415/pdfft?md5=e2e750792076f189cc66befa23ec9567&pid=1-s2.0-S0956566321000415-main.pdf
17. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature
International Journal of Infectious Diseases, 19 April 2021, Volume 107 (Cover date: June 2021), Pages 72-77
Victoria Birlutiu, Alin Iulian Feiereisz, Gabriela Mariana Iancu
https://www.sciencedirect.com/science/article/pii/S1201971221003702/pdfft?md5=c80daf5f611596dfcb73bc8ef837c768&pid=1-s2.0-S1201971221003702-main.pdf
18. C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2–infected primary human airway epithelia
Journal of Allergy and Clinical Immunology, 20 April 2021, Volume 147, Issue 6 (Cover date: June 2021), Pages 2083-2097.e6
Wilfried Posch, Jonathan Vosper, Doris Wilflingseder
https://www.sciencedirect.com/science/article/pii/S0091674921005601/pdfft?md5=31b89db42b9e6bcfc92c339a3e8fec9c&pid=1-s2.0-S0091674921005601-main.pdf
19. Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development
Antiviral Research, 27 January 2021, Volume 187 (Cover date: March 2021), Article 105020
Cheng Liu, Sandro Boland, Jerome Deval
https://www.sciencedirect.com/science/article/pii/S0166354221000103/pdfft?md5=282737669a5805207aead53102a7dda4&pid=1-s2.0-S0166354221000103-main.pdf
20. Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study
European Journal of Cancer, 26 June 2021, Volume 154 (Cover date: September 2021), Pages 167-174
Jan-Malte Placke, Henning Reis, Joachim Klode
https://www.sciencedirect.com/science/article/pii/S0959804921003981/pdfft?md5=b67241b5741d3bd9065fbc983394d370&pid=1-s2.0-S0959804921003981-main.pdf
21. How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
Value in Health, 19 February 2021, Volume 24, Issue 5 (Cover date: May 2021), Pages 625-631
Adrian Towse, Kalipso Chalkidou, Rachel Silverman
https://www.sciencedirect.com/science/article/pii/S1098301521000322/pdfft?md5=13164bad0d5bb27a20c7db5de548ee52&pid=1-s2.0-S1098301521000322-main.pdf
22. Attitudes towards COVID-19 vaccine and reasons for adherence or not among nursing students
Journal of Professional Nursing, 17 July 2021, Volume 37, Issue 5 (Cover date: September–October 2021), Pages 923-927
Michael Belingheri, Davide Ausili, Michele A. Riva
https://www.sciencedirect.com/science/article/pii/S8755722321001162/pdfft?md5=e04b6b777ee9f04eb0684eddd0d4c607&pid=1-s2.0-S8755722321001162-main.pdf
23. Assessing the quality of COVID-19 vaccine videos on video-sharing platforms
Exploratory Research in Clinical and Social Pharmacy, June 2021, Volume 2, Article 100035
Ryan Yanqi Tan, Alyssa Elyn Pua, Kevin Yi-Lwern Yap
https://www.sciencedirect.com/science/article/pii/S2667276621000354/pdfft?md5=0f63cc84dae4bcafafdd8b3a042228a7&pid=1-s2.0-S2667276621000354-main.pdf
24. Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use
Vaccine, 27 February 2021, Volume 39, Issue 16 (Cover date: 15 April 2021), Pages 2295-2302
Mingwang Shen, Jian Zu, Lei Zhang
https://www.sciencedirect.com/science/article/pii/S0264410X2100236X/pdfft?md5=d0d4c4f8b96eff467a40475644d9a58e&pid=1-s2.0-S0264410X2100236X-main.pdf
25. NIH funding for vaccine readiness before the COVID-19 pandemic
Vaccine, 8 March 2021, Volume 39, Issue 17 (Cover date: 22 April 2021), Pages 2458-2466
Anthony E. Kiszewski, Ekaterina Galkina Cleary, Fred D. Ledley
https://www.sciencedirect.com/science/article/pii/S0264410X21002905/pdfft?md5=33ba8b1f77b0a76989bb365af6e1c172&pid=1-s2.0-S0264410X21002905-main.pdf
26. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
Cell Reports, 29 June 2021, Volume 36, Issue 3 (Cover date: 20 July 2021), Article 109400
Traci L. Bricker, Tamarand L. Darling, Adrianus C. M. Boon
https://www.sciencedirect.com/science/article/pii/S2211124721007981/pdfft?md5=c0861986c4959f37f75cfc10d5e77042&pid=1-s2.0-S2211124721007981-main.pdf
27. Key points to keep in mind related to COVID-19 vaccines in people with multiple sclerosis
Multiple Sclerosis and Related Disorders, 16 July 2021, Volume 54 (Cover date: September 2021), Article 103142
Lorna Galleguillos, Ricardo Alonso
https://www.sciencedirect.com/science/article/pii/S2211034821004090/pdfft?md5=b73dfc1c94879198c6ef5f4a08f5682e&pid=1-s2.0-S2211034821004090-main.pdf
28. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021
Multiple Sclerosis and Related Disorders, 22 July 2021, Volume 54 (Cover date: September 2021), Article 103163
Dawn M. Ehde, Michelle K. Roberts, Kevin N. Alschuler
https://www.sciencedirect.com/science/article/pii/S2211034821004302/pdfft?md5=c2f8993d823bd5792df2baae4376b4ab&pid=1-s2.0-S2211034821004302-main.pdf
29. A new fractional mathematical modelling of COVID-19 with the availability of vaccine
Results in Physics, 20 April 2021, Volume 24 (Cover date: May 2021), Article 104213
Pushpendra Kumar, Vedat Suat Erturk, Marina Murillo-Arcila
https://www.sciencedirect.com/science/article/pii/S2211379721003582/pdfft?md5=f595011c5ce463b43c7962c1562cf282&pid=1-s2.0-S2211379721003582-main.pdf
30. An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest
Computers in Biology and Medicine, 30 July 2021, Volume 136 (Cover date: September 2021), Article 104703
Abdullah Al Saba, Maisha Adiba, A. H. M. Nurun Nabi
https://www.sciencedirect.com/science/article/pii/S0010482521004972/pdfft?md5=72086c516e81eaed83233e1ee5869dd3&pid=1-s2.0-S0010482521004972-main.pdf
31. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study
Brain, Behavior, and Immunity, 11 March 2021, Volume 94 (Cover date: May 2021, )Pages 41-50
Elaine Robertson, Kelly S. Reeve, Michaela J. Benzeval
https://www.sciencedirect.com/science/article/pii/S0889159121001100/pdfft?md5=293d047a2e1c01ce43ac70f4c374aca3&pid=1-s2.0-S0889159121001100-main.pdf
32. Factors associated with COVID-19 vaccine trust and hesitancy among adults with chronic conditions
Preventive Medicine Reports, 15 July 2021, Volume 24 (Cover date: December 2021), Article 101484
Marina Arvanitis, Lauren Opsasnick, Michael S. Wolf
https://www.sciencedirect.com/science/article/pii/S2211335521001741/pdfft?md5=da4c759a24832c4d3385735882c1b0fd&pid=1-s2.0-S2211335521001741-main.pdf
33. Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding
Cell Reports, 20 July 2021, Volume 36, Issue 5 (Cover date: 3 August 2021), Article 109493
Jakob Trimpert, Kristina Dietert, Dusan Kunec
https://www.sciencedirect.com/science/article/pii/S2211124721009207/pdfft?md5=77635112aaa709fe1548c2af33e3429b&pid=1-s2.0-S2211124721009207-main.pdf
34. Trajectories of COVID-19 vaccine intentions among U.S. adults: The role of race and ethnicity
SSM - Population Health, 27 May 2021, Volume 15 (Cover date: September 2021), Article 100824
Michael D. Niño, Brittany N. Hearne, Tianji Cai
https://www.sciencedirect.com/science/article/pii/S2352827321000999/pdfft?md5=95b71bd906a75c609e0f5e56bc710c08&pid=1-s2.0-S2352827321000999-main.pdf
35. Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases
Multiple Sclerosis and Related Disorders, 2 August 2021, Volume 55 (Cover date: October 2021), Article 103189
Itay Lotan, Gabriela Romanow, Michael Levy
https://www.sciencedirect.com/science/article/pii/S2211034821004569/pdfft?md5=2564162fa5c214fc9550df876149757f&pid=1-s2.0-S2211034821004569-main.pdf
36. A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Cell Host & Microbe, 4 June 2021, Volume 29, Issue 7 (Cover date: 14 July 2021), Pages 1137-1150.e6
Alexandra Tauzin, Manon Nayrac, Andrés Finzi
https://www.sciencedirect.com/science/article/abs/pii/S1931312821002791
37. Nanocarrier vaccines for SARS-CoV-2
Advanced Drug Delivery Reviews, 9 January 2021, Volume 171 (Cover date: April 2021), Pages 215-239
Jatin Machhi, Farah Shahjin, Bhavesh D. Kevadiya
https://www.sciencedirect.com/science/article/abs/pii/S0169409X21000028
38. SARS-CoV-2 vaccine-induced cerebral venous thrombosis
European Journal of Internal Medicine, 25 May 2021, Volume 89 (Cover date: July 2021), Pages 19-21
Alfonso Ciccone
https://www.sciencedirect.com/science/article/abs/pii/S0953620521001850
39. Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients
American Journal of Obstetrics and Gynecology, 1 February 2021, Volume 224, Issue 5 (Cover date: May 2021), Pages 470-478
Frank A. Chervenak, Laurence B. McCullough, Amos Grünebaum
https://www.sciencedirect.com/science/article/abs/pii/S000293782100082X
40. The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2
Journal of Controlled Release, 21 May 2021, Volume 335 (Cover date: 10 July 2021), Pages 449-456
Hai Huang, Caili Zhang, Xiangrong Song
https://www.sciencedirect.com/science/article/abs/pii/S0168365921002406
41. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
Immunity, 4 February 2021, Volume 54, Issue 3 (Cover date: 9 March 2021), Pages 542-556.e9
Nanda Kishore Routhu, Narayanaiah Cheedarla, Rama Rao Amara
https://www.sciencedirect.com/science/article/abs/pii/S107476132100042X
42. Effectiveness of ChAdOx1 nCOV-19 Vaccine: Experience of a tertiary care institute
Medical Journal Armed Forces India, 26 July 2021, Volume 77, Supplement 2 (Cover date: July 2021), Pages s271-s277
Saurabh Bobdey, S. K. Kaushik, Santosh Karade
https://www.sciencedirect.com/science/article/pii/S0377123721001520
43. Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data
Journal of Autoimmunity, 23 June 2021, Volume 122 (Cover date: August 2021), Article 102685
Luigi Cari, Paolo Fiore, Giuseppe Nocentini
https://www.sciencedirect.com/science/article/pii/S0896841121000937
44. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine
EClinicalMedicine, 4 June 2021, Volume 36 (Cover date: June 2021), Article 100928
Raul Pellini, Aldo Venuti, Gennaro Ciliberto
https://www.sciencedirect.com/science/article/pii/S258953702100208X/pdfft?md5=2988c0c720fbab718a9d42cf201961b3&pid=1-s2.0-S258953702100208X-main.pdf
45. Innovative trial designs and analyses for vaccine clinical development
Contemporary Clinical Trials, 21 November 2020, Volume 100 (Cover date: January 2021), Article 106225
Mengya Liu, Qing Li, Elaine Hoffman
https://www.sciencedirect.com/science/article/pii/S1551714420303037
46. Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
Genomics, 15 May 2021, Volume 113, Issue 4 (Cover date: July 2021), Pages 2158-2170
Rui Wang, Jiahui Chen, Guo-Wei Wei
https://www.sciencedirect.com/science/article/abs/pii/S0888754321001798
47. Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation
Computers in Biology and Medicine, 24 April 2021, Volume 133 (Cover date: June 2021), Article 104420
Abbas Khan, Shahzeb Khan, Dong-Qing Wei
https://www.sciencedirect.com/science/article/abs/pii/S0010482521002146
48. Is the BCG vaccine a useful tool against COVID-19?
Clinics in Dermatology, 16 December 2020, Volume 39, Issue 1 (Cover date: January–February 2021), Pages 98-103
Galina Zhelezova, Valeria Mateeva, Grisha Mateev
https://www.sciencedirect.com/science/article/abs/pii/S0738081X20302534
49. Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2
Journal of Controlled Release, 20 December 2020, Volume 330 (Cover date: 10 February 2021), Pages 529-539
Kyung Soo Park, Joseph D. Bazzill, James J. Moon
https://www.sciencedirect.com/science/article/abs/pii/S0168365920307550
50. Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic
Biologicals, 19 November 2020, Volume 69 (Cover date: January 2021), Pages 76-82
Marc Baay, Bruno Lina, Pieter Neels
https://www.sciencedirect.com/science/article/pii/S1045105620301378/pdfft?md5=dc8e5118e8fbd47011896e0cb404b499&pid=1-s2.0-S1045105620301378-main.pdf
51. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus
Vaccine, 9 January 2021, Volume 39, Issue 7 (Cover date: 12 February 2021), Pages 1087-1095
Jitender Singh, Deepti Malik, Ashvinder Raina
https://www.sciencedirect.com/science/article/pii/S0264410X21000153
52. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Cell Reports, 10 July 2021, Volume 36, Issue 4 (Cover date: 27 July 2021), Article 109452
Ahmed O. Hassan, Swathi Shrihari, Michael S. Diamond
https://www.sciencedirect.com/science/article/pii/S221112472100869X/pdfft?md5=d114eb70b15d8311980dfaa36e1d5696&pid=1-s2.0-S221112472100869X-main.pdf
53. Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2
Vaccine: X9 January 2021, Volume 7 (Cover date: April 2021), Article 100084
T. Christopher Mast, David Heyman, Lyn Finelli
https://www.sciencedirect.com/science/article/pii/S2590136221000012/pdfft?md5=9e892e84765508574f31df5d320e21ca&pid=1-s2.0-S2590136221000012-main.pdf
54. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
EClinicalMedicine, 24 December 2020, Volume 31 (Cover date: January 2021), Article 100689
Pablo Tebas, ShuPing Yang, Laurent M. Humeau
https://www.sciencedirect.com/science/article/pii/S2589537020304338/pdfft?md5=cf753d416d26cce06df38c7864654db0&pid=1-s2.0-S2589537020304338-main.pdf
55. Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus
Nano Today, 19 March 2021, Volume 38 (Cover date: June 2021), Article 101139
Yaling Wang, Yuping Xie, Chunying Chen
https://www.sciencedirect.com/science/article/abs/pii/S1748013221000645
WILEY:
1. Prognostic implications of biventricular strain measurement in COVID-19 patients by speckle-tracking echocardiography
Mohammad Khani MD, Sasan Tavana MD, Mohammadreza Tabary MD, Zahra Naseri Kivi MD, Isa Khaheshi MD
Clinical Cardiology
First published: 06 August 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/clc.23708
2. A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model
Antonia Sophia Peter, Edith Roth, Sebastian R. Schulz, Kirsten Fraedrich, Tobit Steinmetz, Dominik Damm, Manuela Hauke, Elie Richel, Sandra Mueller-Schmucker, Katharina Habenicht, Valentina Eberlein,…
European Journal of Immunology
First published: 06 August 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202149374
3. Decline in Sars‐CoV‐2 antibodies over 6 month follow up in Obstetrical Healthcare workers
Miranda K. Kiefer DO, Kenneth D. Allen DO, Jessica R. Russo, Marwan Ma'ayeh MD, Stephen E. Gee MD, Doug Kniss PhD, Michael Cackovic MD, Maged M. Costantine MD, Kara M. Rood MD
American Journal of Reproductive Immunology
First published: 06 August 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/aji.13490
4. Prognostic utility of pulmonary artery and ascending aorta diameters derived from computed tomography in COVID-19 patients
Mehmet Erdoğan MD, Selçuk Öztürk MD, Mehmet Akif Erdöl MD, Ahmet Kasapkara MD, Muhammed Said Beşler, Bircan Kayaaslan MD, İmran Hasanoğlu MD, Tahir Durmaz MD, Rahmet Güner MD
Echocardiography
First published: 06 August 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/echo.15170
5. Relationship between echocardiographic tricuspid annular plane systolic excursion and mortality in COVID-19 patients: A Meta-analysis
Marco Zuin MD, Gianluca Rigatelli MD PhD, Loris Roncon MD, Giovanni Zuliani MD PhD
Echocardiography
First published: 06 August 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/echo.15175
6. Repetitive saliva-based mass screening as a tool for controlling SARS-CoV-2 transmission in nursing homes
Claude Saegerman, Anne-Françoise Donneau, Niko Speybroeck, Anh Nguyet Diep, Alexandria Williams, Lambert Stamatakis, Wouter Coppieters, Fabienne Michel, Christophe Breuer, Margaux Dandoy, Olivier Ek, Claire Gourzones, Joey Schyns, Emeline Goffin, Frédéric Minner, Véronique Renault, Laurent Gillet, Fabrice Bureau
Transboundary and Emerging Diseases
First published: 06 August 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tbed.14280
7. New pyrazine conjugates: Synthesis, computational studies, and antiviral properties against SARS‐CoV‐2
Israa A. Seliem, Adel S. Girgis, Yassmin Moatasim, Ahmed Kandeil, Ahmed Mostafa, Mohamed A. Ali, Mohamed S. Bekheit, Siva S Panda
ChemMedChem
First published: 05 August 2021
https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202100476
8. Therapeutic interventions of remdesivir in diabetic and non-diabetic COVID-19 patients: A prospective observational study conducted on Pakistani population
Qiadat Hasnain Qureshi, Taimoor Ashraf, Kanwal Rehman, Muhammad Kaleem Khosa, Muhammad Sajid Hamid Akash
Journal of Medical Virology
First published: 05 August 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27256
9. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome
Wangsheng Deng, Jiaxing Zeng, Shunyu Lu, Chaoqian Li
IET Systems Biology
First published: 05 August 2021
https://ietresearch.onlinelibrary.wiley.com/doi/epdf/10.1049/syb2.12034
10. Incidence and risk factors for persistent symptoms in adults previously hospitalised for COVID-19
Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova, Anastasia Shikhaleva, Aysylu Gamirova, Oleg Blyuss, Nikita Nekliudov, Polina Bugaeva, Margarita Andreeva, Audrey DunnGalvin…
Clinical & Experimental Allergy
First published: 05 August 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/cea.13997
SPRINGER NATURE
1. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report
Toyotaka Iguchi, Hikari Umeda, Michie Kojima, Yuri Kanno, Yuta Tanaka… in Drug Safety (2021)
https://link.springer.com/content/pdf/10.1007%2Fs40264-021-01104-9.pdf
2. Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility
Ali Golchin in Stem Cell Reviews and Reports (2021)
https://link.springer.com/content/pdf/10.1007%2Fs12015-020-10046-1.pdf
3. Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Khalid Mohamed Adam in Tropical Diseases, Travel Medicine and Vaccines (2021)
https://link.springer.com/content/pdf/10.1186%2Fs40794-021-00147-1.pdf
4. Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
Carl H. Göbel, Axel Heinze, Sarah Karstedt, Mascha Morscheck… in Pain and Therapy (2021)
https://link.springer.com/content/pdf/10.1007%2Fs40122-021-00296-3.pdf
5. Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine
Zaitun Zakaria, Nur Asma Sapiai, Abdul Rahman Izaini Ghani in Acta Neurochirurgica (2021)
https://link.springer.com/content/pdf/10.1007%2Fs00701-021-04860-w.pdf
6. Peptide enzyme‐linked immunosorbent assay (pELISA) as a possible alternative to the neutralization test for evaluating the immune response to IBV vaccine
Qi Wu, Zhixian Lin, Jinsen Wu, Kun Qian, Hongxia Shao… in BMC Veterinary Research (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12917-021-02757-5.pdf
7. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries
Malia Skjefte, Michelle Ngirbabul, Oluwasefunmi Akeju… in European Journal of Epidemiology (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10654-021-00728-6.pdf
8. Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement
Laurence Katznelson, Mônica Gadelha in Pituitary (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11102-021-01130-x.pdf
9. On BCG Vaccine Protection from COVID-19: A Review
Narges Bagheri, Hesam Montazeri in SN Comprehensive Clinical Medicine (2021)
https://link.springer.com/content/pdf/10.1007%2Fs42399-021-00835-1.pdf
10. Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV
Violeta J. Rodriguez, Maria L. Alcaide, Ana S. Salazar… in AIDS and Behavior (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10461-021-03350-5.pdf